TMED7-TICAM2 Readthrough (TMED7-TICAM2) (Middle Region) Antikörper
Kurzübersicht für TMED7-TICAM2 Readthrough (TMED7-TICAM2) (Middle Region) Antikörper (ABIN5514538)
Target
Alle TMED7-TICAM2 Readthrough (TMED7-TICAM2) ProdukteReaktivität
Wirt
Klonalität
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Sequenz
- AEHSNTTEGP TGKQEGAQSV EEMFEEEAEE EVFLKFVILH AEDDTDEALR
-
Aufreinigung
- Affinity purified
-
Immunogen
- The immunogen is a synthetic peptide directed towards the middle region of human TMED7-TICAM2
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 23 % sucrose.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
- TMED7-TICAM2 Readthrough (TMED7-TICAM2)
-
Andere Bezeichnung
- TMED7-TICAM2
-
Hintergrund
-
This locus represents naturally occurring read-through transcription between the neighboring transmembrane emp24 protein transport domain containing 7 (TMED7) and toll-like receptor adaptor molecule 2 (TICAM2) genes. Alternative splicing results in multiple transcript variants, one of which encodes a fusion protein that shares sequence identity with the products of each individual gene. This fusion product functions to negatively regulate the adaptor MyD88-independent toll-like receptor 4 pathway.
Protein Size: 235 -
Gen-ID
- 100302736
-
NCBI Accession
- NM_001164468, NP_001157940
-
UniProt
- Q86XR7
Target
-